Insider · CIK 0001299153

ANDREWS RONALD ASBURY

Reports to the SEC for 7 companies · HOUSTON, TX

sec.gov

Transactions

Companies

Filings

CIK

0001299153

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	CNSYCERENOME, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−921 sh	—	—	1,843
2026-10-01	CNSYCERENOME, INC.M Exercise/Conversion	Director	MExercise/Conversion	+921 sh	—	—	1,843
2026-07-01	CNSYCERENOME, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−922 sh	—	—	2,764
2026-07-01	CNSYCERENOME, INC.M Exercise/Conversion	Director	MExercise/Conversion	+922 sh	—	—	922
2026-05-14	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,686 sh	—	—	3,686
2026-05-14	CNSYCERENOME, INC. · Restricted Stock UnitsA Award	Director	AAward	+3,686 sh	—	—	3,686
2026-05-14	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,600 sh	—	—	1,600
2026-01-02	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,500 sh	—	—	1,500
2025-10-15	PRPOPrecipio, Inc.A Award	Director	AAward	+568 sh	$17.58	+$9,985.44	15,708
2025-10-15	PRPOPrecipio, Inc.A Award	Director	AAward	+568 sh	$17.58	+$9,985.44	15,796
2025-07-16	PRPOPrecipio, Inc.A Award	Director	AAward	+676 sh	$14.78	+$9,991.28	15,228
2025-04-15	PRPOPrecipio, Inc.A Award	Director	AAward	+1,785 sh	$5.60	+$9,996	14,552
2025-01-15	PRPOPrecipio, Inc.A Award	Director	AAward	+1,639 sh	$6.10	+$9,997.9	12,767
2025-01-14	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,000 sh	—	—	1,000
2024-10-15	PRPOPrecipio, Inc.A Award	Director	AAward	+1,510 sh	$6.62	+$9,996.2	11,128
2024-08-31	PRPOPrecipio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−258 sh	—	—	0
2024-08-31	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+103 sh	—	—	103
2024-08-31	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,000 sh	—	—	2,000
2024-08-31	PRPOPrecipio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	—	—	0
2024-08-31	PRPOPrecipio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−103 sh	—	—	0
2024-08-31	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,250 sh	—	—	1,250
2024-08-31	PRPOPrecipio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,250 sh	—	—	0
2024-08-31	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+258 sh	—	—	258
2024-07-15	PRPOPrecipio, Inc.A Award	Director	AAward	+2,157 sh	$4.63	+$9,986.91	9,618
2024-06-21	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,000 sh	—	—	1,000
2024-04-15	PRPOPrecipio, Inc.A Award	Director	AAward	+3,153 sh	$6.66	+$21K	7,461
2023-10-24	PRPOPrecipio, Inc.A Award	Director	AAward	+4,005 sh	—	—	4,308
2023-09-12	PRPOPrecipio, Inc.A Award	Director	AAward	+6,060 sh	—	—	6,060
2023-01-06	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-12-07	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockA Award	Director, Former CEO	AAward	+50K sh	—	—	50,000
2022-12-01	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockD Disposition to Issuer	Director, Former CEO	DDisposition to Issuer	−20K sh	—	—	0
2022-12-01	IMDXInsight Molecular Diagnostics Inc.M Exercise/Conversion	Director, Former CEO	MExercise/Conversion	+250K sh	—	—	583,212
2022-12-01	IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Former CEO	MExercise/Conversion	−250K sh	—	—	0
2022-12-01	IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsD Disposition to Issuer	Director, Former CEO	DDisposition to Issuer	−250K sh	—	—	250,000
2022-12-01	IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsD Disposition to Issuer	Director, Former CEO	DDisposition to Issuer	−35K sh	—	—	0
2022-12-01	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockD Disposition to Issuer	Director, Former CEO	DDisposition to Issuer	−93.8K sh	—	—	281,250
2022-12-01	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockD Disposition to Issuer	Director, Former CEO	DDisposition to Issuer	−300K sh	—	—	0
2022-12-01	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockD Disposition to Issuer	Director, Former CEO	DDisposition to Issuer	−500K sh	—	—	0
2022-12-01	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockD Disposition to Issuer	Director, Former CEO	DDisposition to Issuer	−50K sh	—	—	0
2022-12-01	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockD Disposition to Issuer	Director, Former CEO	DDisposition to Issuer	−45K sh	—	—	0
2022-12-01	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockD Disposition to Issuer	Director, Former CEO	DDisposition to Issuer	−950K sh	—	—	0
2022-08-16	IMDXInsight Molecular Diagnostics Inc.P Purchase	Director, Former CEO	PPurchase	+40K sh	$0.96	+$38.4K	333,212
2022-03-16	IMDXInsight Molecular Diagnostics Inc.P Purchase	Director, Former CEO	PPurchase	+50K sh	$1.28	+$64.1K	293,212
2022-03-15	IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsA Award	Director, Former CEO	AAward	+500K sh	—	—	500,000
2022-03-15	IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsA Award	Director, Former CEO	AAward	+35K sh	—	—	35,000
2022-03-15	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockA Award	Director, Former CEO	AAward	+375K sh	—	—	375,000
2022-03-15	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockA Award	Director, Former CEO	AAward	+200K sh	—	—	200,000
2022-03-15	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockA Award	Director, Former CEO	AAward	+300K sh	—	—	300,000
2022-01-11	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-08-03	PRPOPrecipio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Oct 14
ANDREWS RONALD ASBURY0001193125-26-409861
SEC(opens sec.gov)
Jul 14
ANDREWS RONALD ASBURY0001193125-26-292654
SEC(opens sec.gov)
May 184
ANDREWS RONALD ASBURY0001193125-26-228922
SEC(opens sec.gov)
Jan 204/A
ANDREWS RONALD ASBURY0001104659-26-005081
SEC(opens sec.gov)
Jan 64
ANDREWS RONALD ASBURY0001104659-26-001334
SEC(opens sec.gov)
Oct 164
ANDREWS RONALD ASBURY0001104659-25-100104
SEC(opens sec.gov)
Jul 184
ANDREWS RONALD ASBURY0001104659-25-069057
SEC(opens sec.gov)
Apr 174
ANDREWS RONALD ASBURY0001104659-25-036085
SEC(opens sec.gov)
Jan 164
ANDREWS RONALD ASBURY0001104659-25-004156
SEC(opens sec.gov)
Jan 164
ANDREWS RONALD ASBURY0001104659-25-004164
SEC(opens sec.gov)
Oct 174
ANDREWS RONALD ASBURY0001104659-24-109550
SEC(opens sec.gov)
Sep 64
ANDREWS RONALD ASBURY0001104659-24-097790
SEC(opens sec.gov)

Companies

Address

6420 LEVIT GREEN BOULEVARD SUITE 310

HOUSTON, TX, 77021